A time-resolved fluorescence immunoassay for the determination of a novel respiratory therapeutic agent, AR-C68397XX (Viozan™) in human plasma
- 27 November 2000
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 23 (6) , 947-954
- https://doi.org/10.1016/s0731-7085(00)00374-5
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- A RIA combined with SPE for the determination of a dual D2-receptor and β2-adrenoceptor agonist, AR-C68397XX, in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2000
- International Harmonization and Consensus DIA Meeting on Bioavailability and Bioequivalence Testing Requirements and StandardsDrug Information Journal, 1991
- Method validation in the bioanalytical laboratoryJournal of Pharmaceutical and Biomedical Analysis, 1990